Raymond James analyst Andrew Cooper upgraded Haemonetics (NYSE: HAE) from Outperform to Strong Buy with a price target of $120.00.The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE